1mg semaglutide Ozempic Injection – Once-Weekly GLP-1 for T2D & Cardiovascular Protection Losing weight and keeping it off can lessen the many health risks that come with obesity Frequently Asked Questions | Ozempic®

Nature 458, 839840

CagriSema is a combination strategy: It pairs cagrilintide, a long-acting amylin analog, with semaglutide, a GLP-1 receptor agonist

These GLP-1 agonists help the body to produce enough insulin when blood sugar levels are high, reduce the sugar thats released in your blood, and help you to feel fuller longer, so fewer calories are consumed

Obesity, as a global chronic disease characterized by excessive fat accumulation, affects the health of approximately 650 million people and is associated with an increased risk of multiple metabolic complications, such as Type 2 diabetes and non-alcoholic fatty liver disease, as well as cardiovascular diseases and mechanical issues, including osteoarthritis and obstructive sleep apnea

A structure that feels effortless is one you keep

In addition to appetite regulation, semaglutide contributes to metabolic control by slowing gastric emptying